What are the adverse effects of Extracorporeal Shock Wave Lithotripsy (ESWL) and how are they managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adverse Effects of ESWL: Incidence and Management

ESWL has fewer complications than percutaneous nephrolithotomy or ureteroscopy, with most adverse effects being mild (Clavien grade I-II in 18.43% of cases) and managed conservatively, though serious complications (Clavien grade III-IV) occur in 2.48% of patients. 1

Classification of Adverse Effects by Severity

Minor Complications (Clavien Grade I-II)

Stone Fragment-Related Complications:

  • Colicky pain occurs in approximately 40% of patients and represents the most frequent complication 2
  • Macroscopic hematuria develops in 17.2% of cases 1
  • Steinstrasse (stone street formation) occurs in 4-24.2% of patients 1, 2
  • Renal colic affects 2-4% of patients 1
  • Residual fragment regrowth occurs in 21-59% of cases 1

Management of Minor Complications:

  • Most minor complications resolve with conservative management or minimal intervention 2
  • Medical expulsive therapy (MET), mechanical percussion, and diuretics can enhance stone passage and reduce analgesic needs 1
  • Routine pre-stenting before ESWL does not improve stone-free rates but may reduce steinstrasse formation 1

Infectious Complications

Incidence:

  • Bacteriuria develops in 7.7-23% of patients with non-infected stones 1
  • Symptomatic bacteriuria occurs in 9.7% of patients, with Escherichia coli being the most common causative organism (30.4%) 2
  • Sepsis is rare at 0.15% 1

Management:

  • Perioperative antibiotic prophylaxis should be offered to all patients undergoing ESWL 1
  • The choice of antibiotic prophylaxis should be tailored to institutional or regional antimicrobial susceptibility patterns 1

Tissue-Related Complications

Renal Complications:

  • Asymptomatic hematoma occurs in 1.2% of cases 1
  • Symptomatic hematoma develops in 0.21% of patients 1
  • A decline in kidney function has been reported in small case series, particularly in children with primary hyperoxaluria, though this may reflect the natural disease course rather than ESWL-specific injury 1

Cardiovascular Complications:

  • Cardiac dysrhythmias occur in 11-29% of patients 1
  • In patients with pacemakers or defibrillators, ESWL is feasible with technical precautions; newer lithotripters may eliminate the need for reprogramming 1

Major Complications (Clavien Grade III-IV)

  • Auxiliary procedures are required in 6-9% of cases 1
  • Serious complications (Clavien grade III-IV) occur in 2.48% of patients 1

Long-Term Concerns

Hypertension and Diabetes:

  • The link between ESWL and hypertension/diabetes remains unclear, with no conclusive evidence of long-term adverse effects 1, 3
  • Current evidence does not support withholding ESWL based on diabetes concerns alone 3

Risk Mitigation Strategies

Technical Optimization:

  • Decreasing shockwave frequency from 120 to 60-90 shockwaves per minute improves stone-free rates and reduces tissue damage 1
  • Stepwise energy ramping minimizes renal injury 1
  • Proper acoustic coupling between the treatment head and skin is crucial, as air pockets can deflect shockwaves 1
  • Operator experience significantly impacts outcomes; better results are observed when ESWL is performed by experienced clinicians with precise imaging control 1

Special Populations and Contraindications

Absolute Contraindications:

  • Pregnancy 1
  • Bleeding disorders 1
  • Uncontrolled urinary tract infection 1
  • Arterial aneurysm near the stone 1
  • Anatomic obstructions distal to the stone 1

High-Risk Bleeding Procedures:

  • ESWL is classified as a procedure with high bleeding risk 1
  • Patients with bleeding disorders or receiving antithrombotic therapy should be referred to an internist for appropriate therapeutic measures before proceeding 1

Critical Pitfalls to Avoid

  • Avoid dehydration in the perioperative period, particularly in patients with primary hyperoxaluria, as even mild dehydration can lead to acute kidney injury 1
  • Do not perform routine post-procedure stenting after uncomplicated ESWL, as this may increase morbidity without improving outcomes 1
  • Recognize that ESWL has inferior outcomes compared to percutaneous nephrolithotomy for complex stones, particularly in primary hyperoxaluria patients where stone-free rates may be as low as 20-47% 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ESWL and Diabetes: No Established Causal Relationship

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.